Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".

Oxid Med Cell Longev

Laboratory of Pathophysiology of Cachexia and Metabolism of Skeletal Muscle, IRCCS San Raffaele Pisana, 00166 Rome, Italy.

Published: June 2019

[This corrects the article DOI: 10.1155/2018/7582730.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617926	PMC
http://dx.doi.org/10.1155/2019/9601435	DOI Listing

Publication Analysis

corrigendum "chemotherapeutic

"chemotherapeutic drugs

drugs mitochondrial

mitochondrial dysfunction

dysfunction focus

focus doxorubicin

doxorubicin trastuzumab

trastuzumab sunitinib"

sunitinib" [this

[this corrects

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!